VP, Corporate Development, Lynx Biosciences / Co-Founder, Alkyon Therapeutics
Benjamin Titz, based in San Diego, CA, US, is currently a Co-Founder at Alkyon Therapeutics and the Vice President of Corporate Development at Lynx Biosciences. Ben brings experience from previous roles at OnLume and Cellectar Biosciences, Inc. He holds a PhD and MSc in Medical Physics from the University of Wisconsin-Madison. He is equiped with a robust skill set that includes Medical Physics, Molecular Imaging, Image Analysis, Biomedical Engineering, Radiation Therapy and more. He has 10 publications and two granted patents. He has received many awards and accolades from NIH/NCI, the University of Wisconsin-Madison, Standard Imaging, and SDVG.
